SecBot SecBot
6-K ·Filed May 13, 2026

GNMSF

GENMAB A/S
NEUTRAL
Impact 2/10
Horizonimmediate Processed5mo ago SEC0001434265-26-000083
Notable filing: 6-K
Actionable Insight • Neutral

This is a routine administrative filing with no trading implications. Monitor upcoming earnings or pipeline updates for material catalysts.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
GNMSF ▲ +9.98% at T+60d
NEUTRAL call +9.98% · α vs SPY +5.54% · entry $268.24 → $295.00
Entry = T+0 close
May 13, 2026
via day close
T+1d
-1.11%
call -1.11% · α -1.88%
$265.27
settled 6mo ago
T+5d
-1.11%
call -1.11% · α +0.05%
$265.27
settled 5mo ago
T+20d
-7.17%
call -7.17% · α -6.56%
$249.00
settled 5mo ago
T+60d
+9.98%
call +9.98% · α +5.54%
$295.00
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Genmab filed its updated Articles of Association as a 6-K, reflecting routine corporate governance updates including authorized capital increases and employee warrant programs. No financial results, material events, or strategic changes were disclosed.

Key Facts

  • Share capital is DKK 62,353,067 divided into shares of DKK 1 each.
  • Board authorized until March 12, 2029 to increase share capital by up to DKK 6,600,000 without pre-emption rights.
  • Multiple warrant programs for employees (excluding executive management) with 3-year vesting and 7-year expiry.
  • No financial results, guidance, M&A, or material operational updates in this filing.

Financial Impact

No material financial impact; routine governance filing.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
70% bullish (27 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001434265-26-000083
Document: gmab_20260513x6k.htm0001434265-26-000083
Document: 0001434265-26-000083-index-headers.html0001434265-26-000083
Document: 0001434265-26-000083-index.html0001434265-26-000083
Document: 0001434265-26-000083.txt0001434265-26-000083
10 reports for GNMSF
Performance horizon
Filters
Rows
Reports for GNMSF — sortable, filterable
TypeNow
May 29, 2026
21w ago
6-K
NEUTRAL ★ 2/10
$251.55 $262.00▲ +4.15%▲ +5.45%$439.05 (+74.54%)
May 13, 2026
23w ago
6-K
NEUTRAL ★ 2/10
$268.24 $249.00▼ −7.17%▼ −6.56%$439.05 (+63.68%)
May 12, 2026
24w ago
6-K
NEUTRAL ★ 1/10
$264.64 $249.00▼ −5.91%▼ −4.18%$439.05 (+65.90%)
May 8, 2026
24w ago
6-K
NEUTRAL ★ 2/10
$259.60 $249.00▼ −4.08%▼ −3.78%$439.05 (+69.13%)
Apr 17, 2026
27w ago
6-K
NEUTRAL ★ 3/10
$281.75 $265.27▼ −5.85%▼ −11.22%$439.05 (+55.83%)
Apr 17, 2026
27w ago
6-K
NEUTRAL ★ 2/10
$281.75 $265.27▼ −5.85%▼ −11.22%$439.05 (+55.83%)
Apr 14, 2026
28w ago
6-K
NEUTRAL ★ 4/10
$273.25 $259.60▼ −5.00%▼ −11.29%$439.05 (+60.68%)
Apr 1, 2026
29w ago
6-K
NEUTRAL ★ 2/10
$265.00 $255.25▼ −3.68%▼ −13.40%$439.05 (+65.68%)
Apr 1, 2026
29w ago
6-K
NEUTRAL ★ 2/10
$265.00 $255.25▼ −3.68%▼ −13.40%$439.05 (+65.68%)
Mar 30, 2026
30w ago
6-K
NEUTRAL ★ 2/10
$265.00 $255.25▼ −3.68%▼ −13.10%$439.05 (+65.68%)
Showing 10 of 10

US Market Status

Market Closed — Opens Thu (9h 42m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 13, 2026